The neurotoxicity of soluble Aβ oligomers is thought to be predominant in the preclinical stage of the disease, while soluble tau oligomers are involved in the progression of neurodegeneration in the prodromal period and in dementia [24,95]. Here, MAPT is linked to dementia.